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ABSTRACT
Genetically obese (fa/fa) Zucker rats present an impaired response
of hepatic glucose production to the inhibition by insulin. In this work,
we have investigated the modulation by this hormone of epinephrine-
stimulated gluconeogenesis, in hepatocytes isolated from obese (fa/
fa) rats and their lean (Fa/-) littermates. Epinephrine (1 mM) caused
a maximal stimulation of [14C]lactate conversion to [14C]glucose in
hepatocytes isolated from either obese or lean animals. The stimu-
lation of gluconeogenesis by epinephrine was accompanied by a sig-
nificant reduction of fructose 2,6-bisphosphate levels, an inactivation
of both pyruvate kinase and 6-phosphofructo 2-kinase, and by a 2-fold
increase in the cellular concentrations of cAMP. The presence of
insulin in the incubation medium antagonized, in a concentration-
dependent manner, the effects of epinephrine. In hepatocytes isolated
from lean rats, the reversion caused by insulin was complete, the
concentration required for half-maximal insulin action ranging from
0.22 to 0.56 nM. In contrast, in obese rat hepatocytes, insulin only
partially blocked epinephrine-mediated effects, and the sensitivity to
insulin was 2- to 4-fold lower, as indicated by the corresponding
half-maximal insulin action values. Furthermore, insulin (10 nM)
almost completely blocked the increase in cAMP levels induced by
epinephrine in lean rat hepatocytes, whereas it only provoked a small
and nonsignificant reduction of epinephrine-stimulated levels of the
cyclic nucleotide in hepatocytes obtained from obese rats. (Endocri-
nology 138: 2443–2448, 1997)
OBESITY IN the (fa/fa) Zucker rat is inherited as a re-cessive gene mutation, localized in chromosome 5 (1).
Genetic mapping and genomic analysis have allowed the
identification of fa as a mutation of the leptin receptor gene
(2). The homozygous (fa/fa) rats show insulin resistance with
hyperinsulinemia, hyperlipidemia, normal glycemia or mild
hyperglycemia, and abnormal oral glucose tolerance (for re-
views see Refs. 3–6).
In vitro (7–10) and in vivo (11, 12) studies have demon-
strated that insulin resistance in genetically obese Zucker rats
affects peripheral tissues, such as muscle and adipose tissue.
The presence of insulin resistance at the hepatic level also
was suggested by in vivo studies, in which it was observed
that, as compared with lean (Fa/-) rats, the estimated hepatic
glucose output in the obese animals was not reduced in spite
of the presence of basal hyperinsulinemia (11); only after the
infusion of very high concentrations of insulin was hepatic
glucose production suppressed (12). More recently, we have
demonstrated a decreased responsiveness to insulin of basal
gluconeogenesis from lactate, and of F-2,6-P2 levels, as well
as of pyruvate kinase and 6-phosphofructo 2-kinase (PFK-2)
activities, in hepatocytes isolated from obese (fa/fa) rats, as
compared with that observed in lean rat hepatocytes (13).
In this work, we have studied the modulation by insulin
of epinephrine-stimulated gluconeogenesis, in hepatocytes
isolated from obese (fa/fa) Zucker rats and their lean (Fa/-)
littermates. Our results show that, in hepatocytes isolated
from lean (Fa/-) rats, insulin (in a concentration-dependent
manner) completely antagonized the stimulation of lactate
gluconeogenesis elicited by a saturating concentration of epi-
nephrine (1 mm), as well as the effects of this adrenergic agent
on F-2,6-P2 levels and pyruvate kinase and PFK-2 activities.
In contrast, insulin only partially blocked the metabolic ac-
tions of epinephrine in hepatocytes isolated from obese (fa/fa)
rats, these cells being less sensitive to modulation by insulin.
Moreover, the inhibition by insulin (10 nm) of the increase in
cAMP levels elicited by epinephrine also was impaired in
hepatocytes obtained from obese rats.
Materials and Methods
Reagents
Human insulin (Actrapid HM) was obtained from Novo Industri A/S
(Copenhagen, Denmark). Collagenase A, F-2,6-P2, substrates, auxiliary
enzymes, and coenzymes were purchased from Boehringer Mannheim
(Mannheim, Germany). Epinephrine [(1)-bitartrate salt] was obtained
from Sigma (St. Louis, MO). l-[U-14C]lactate (150 mCi/mmol) was pro-
vided by Amersham International (Aylesbury, UK). The remaining re-
agents, all of analytical grade, were from Boehringer, Sigma, or Merck
(Darmstadt, Germany).
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Animals
Male lean (Fa/-) and genetically obese (fa/fa) rats weighing 300–360
and 430–500 g, respectively, were obtained from Criffa (Barcelona,
Spain). The rats were 14–17 weeks old at the time of experiments. They
were fed with a standard chow (A 04 Panlab S.L., Barcelona, Spain) and
water ad libitum, and were housed in animal quarters at constant tem-
perature (23 C) with a fixed (12-h) light cycle.
Hepatocyte isolation and cell incubations
Hepatocytes were isolated by perfusion of the liver with collagenase
(14). Cells were suspended in Krebs-Henseleit medium (40–60 mg wet
wt/ml) in the presence of 10 mm glucose and incubated in stoppered
20-ml vials, at 37 C, with agitation (100 strokes/min). The gas phase was
95% O2 and 5% CO2. The viability of the isolated hepatocytes was
evaluated by the trypan blue test; usually 90–95% of the cells excluded
the stain.
Gluconeogenesis was estimated by the rate of [U-14C]lactate conver-
sion to [14C]glucose, from a mixture of [U-14C]lactate/pyruvate (2/0.2
mm; 0.5 mCi/mmol) (15). Hepatocytes were preincubated in Krebs-
Henseleit medium in the presence of 10 mm glucose for 27 min. Then,
saline or insulin was added to the hepatocyte suspensions, and the
preincubation further continued. Three minutes later, saline or epineph-
rine, together with the gluconeogenic precursor, were added to the cell
suspensions (zero time of incubation). At the indicated times, aliquots
of cell suspensions were taken to assay gluconeogenesis, F-2,6-P2, cAMP,
or enzyme activities. The actual specific activity of [14C]lactate was
assayed in aliquots of cell suspensions taken at zero time.
Biochemical procedures
As previously described (15), hepatocyte F-2,6-P2 was measured in
aliquots of cell suspensions, taken after 10 min incubation, by the ability
of this metabolite to activate potato tuber PPi:fructose 6-phosphate
1-phosphotransferase (16). For the assay of cAMP, aliquots of cell sus-
pensions were taken after ten min incubation; the cyclic nucleotide was
determined in cells plus medium using a radioimmunological method
(cAMP (125I)RIA Kit, Du Pont de Nemours, Bad Homburg, Germany),
as described elsewhere (14). Reported methods were used to assay
pyruvate kinase activity (17) and the active form of PFK-2 (18). Pyruvate
kinase was measured in the presence of 0.15 mm phosphoenolpyruvate.
Protein was assayed by the method of Lowry et al. (19) using BSA as
standard; 1 g of packed hepatocytes corresponded to 220 6 5 mg of
protein.
Statistical analysis
Statistical significance of differences between values was calculated
by the paired and unpaired Student’s t test. The differences were con-
sidered statistically significant when P-value was less than 0.05. The
concentrations of insulin corresponding to the half-maximal effects
(EC50) were calculated by the nonlinear equation fitting utility of the
graphics program Fig.P (Fig.P Software Corporation, Durham, NC).
Results
Basal gluconeogenesis from lactate was significantly re-
duced in hepatocytes isolated from obese (fa/fa) rats, as com-
pared with that measured in lean (Fa/-) rat hepatocytes
(0.50 6 0.06 and 1.96 6 0.15 mmol of lactate converted to
glucose/g cell 3 20 min, respectively; n 5 3; P , 0.01). These
results are in agreement with the reduction of lactate glu-
coneogenesis observed by Bloxham and York (20) and by our
own group (13) in hepatocytes isolated from genetically
obese rats. To select a saturating concentration of epineph-
rine, we assayed the influence of increasing concentrations of
this catecholamine on hepatocyte gluconeogenesis from a
mixture of [14C]lactate-pyruvate, in liver cells isolated from
either obese or lean animals. As shown in Fig. 1, incubation
with epinephrine caused a dose-dependent stimulation of
[14C]lactate conversion to [14C]glucose; a maximal stimula-
tion of hepatocyte gluconeogenesis was already achieved in
the presence of 1 mm epinephrine in both types of cells. The
calculated EC50 values of epinephrine were 26.9 and 14.7 nm,
respectively, for obese and lean rat hepatocytes. It is of note
that although the maximal rate of epinephrine-stimulated
gluconeogenesis was much higher in lean rat hepatocytes
than in hepatocytes isolated from obese animals, the re-
sponse to saturating concentrations of epinephrine actually
was more marked in obese rat liver cells than in lean rat
hepatocytes (about 4- and 1.8-fold, respectively, as compared
with the corresponding basal gluconeogenesis). However,
when the areas under the curves for obese and for lean rat
liver cells were calculated, the increments over the corre-
sponding basal rate of gluconeogenesis caused by epineph-
rine were not significantly different (respectively, 5.98 6 0.46
and 6.94 6 0.37; values are expressed in arbitrary units; P .
0.05; n 5 4 observations from two experiments). This indi-
cates that the stimulation of gluconeogenesis from lactate
caused by epinephrine was quantitatively similar in obese
and lean rat hepatocytes.
In hepatocytes incubated with 1 mm epinephrine, the ad-
ditional presence of insulin in the incubation medium re-
duced epinephrine-stimulated gluconeogenesis in a concen-
tration-dependent manner (Fig. 2). In hepatocytes isolated
from lean rats, a complete reversion of the stimulation of
gluconeogenesis caused by epinephrine was observed in the
presence of 0.1 mm insulin, 0.35 nm being the calculated EC50
value. In contrast, in obese rat hepatocytes, the reversion of
the epinephrine effect was not complete (P , 0.05, for 0.1 mm
insulin vs. the corresponding basal value in the absence of
FIG. 1. Dose-response curve of the epinephrine effect on basal glu-
coneogenesis in hepatocytes isolated from lean (E,F) or obese (M,f)
Zucker rats. Hepatocytes were suspended in Krebs-Henseleit medium
in the presence of 10 mM glucose and preincubated for 30 min at 37
C. Then, a mixture of [U-14C]lactate-pyruvate together with saline or
epinephrine at the indicated concentrations was added, and the in-
cubation continued. Gluconeogenesis was assayed in aliquots of the
cell suspensions taken after 20 min of incubation. Results are ex-
pressed as mean 6 SEM of four observations from two experiments. By
unpaired Student’s t test: *, P , 0.05; **, P , 0.01; ***, P , 0.005 (vs.
basal incubations). Basal values were obtained in hepatocytes incu-
bated in the absence of hormones.
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hormones), and the apparent sensitivity to insulin was lower
than that observed in lean rat hepatocytes, with a calculated
EC50 value of 1.4 nm.
The action of insulin on the activities of pyruvate kinase
and PFK-2, enzymes which play a key role in the short-term
hormonal control of gluconeogenesis (21, 22), also was eval-
uated in liver cells incubated with epinephrine. According to
previous reports (13, 20, 23–25), obese rat hepatocytes
showed higher basal levels of pyruvate kinase activity (0.15
mm phosphoenolpyruvate) than those isolated from lean rats
(61.9 6 2.6 and 26.4 6 1.0 U/g of cells, respectively; n 5 4;
P , 0.001). As expected, epinephrine caused a marked in-
activation of pyruvate kinase (about 60%) in liver cells iso-
lated from both animal groups (Fig. 3A). The presence of
insulin antagonized, in a dose-dependent manner, the effects
of epinephrine on this enzymatic activity. In lean rat hepa-
tocytes, the reversion caused by insulin was complete, and
the calculated EC50 value was 0.56 nm. On the contrary, in
hepatocytes isolated from obese rats, insulin (even at satu-
rating concentrations) only partially antagonized epineph-
rine-mediated pyruvate kinase inactivation (P , 0.05, for 0.1
mm insulin vs. the corresponding basal value in the absence
of hormones). Furthermore, these cells showed a lower sen-
sitivity to insulin than that observed in lean rat hepatocytes,
with an EC50 value of 1.6 nm (Fig. 3A).
In good agreement with other reports (13, 26), PFK-2 a
activity was significantly higher in liver cells isolated from
obese rats than in those obtained from lean animals (7.33 6
0.35 and 6.07 6 0.27 mU/g of cells, respectively; n 5 4; P ,
0.05). As shown in Fig. 3B, epinephrine also caused the in-
activation of PFK-2 in both lean and obese rat hepatocytes
(about 50% and 60% inactivation, respectively). The addi-
tional presence of insulin in the incubation medium antag-
onized, in a concentration-dependent fashion, the effects of
epinephrine in hepatocytes isolated from either obese or lean
rats. In the latter cells, the reactivation of PFK-2 caused by 0.1
mm insulin led to a value even higher than the basal level
estimated in the absence of hormones (P , 0.05). On the
contrary, in obese rat hepatocytes, insulin did not antagonize
the epinephrine-mediated inactivation of PFK-2 completely
(P , 0.05, for 0.1 mm insulin vs. the corresponding basal
value), and the apparent sensitivity to insulin was lower than
that observed in lean rat cells (EC50 values of 0.22 and 0.89
nm for hepatocytes isolated from lean and obese animals,
respectively).
Considering that F-2,6-P2 is a key regulatory metabolite in
the hormonal control of hepatic gluconeogenesis (21, 22), we
also have studied the modulation by epinephrine and insulin
of the content of this metabolite in hepatocytes isolated from
obese (fa/fa) rats and their lean littermates. As previously
reported (13, 25, 26), obese rat hepatocytes showed a marked
FIG. 2. Dose-response curve of the insulin effect on epinephrine-stim-
ulated gluconeogenesis in hepatocytes isolated from lean (E,F) or
obese (M,f) Zucker rats. Hepatocytes were suspended in Krebs-
Henseleit medium in the presence of 10 mM glucose and preincubated
for 27 min at 37 C. Then, saline or insulin at the indicated concen-
trations was added to the incubation medium. Three minutes later,
a mixture of [U-14C]lactate-pyruvate together with epinephrine (1
mM) was added, and the incubation continued. Gluconeogenesis was
assayed in aliquots of the cell suspensions taken after 20 min of
incubation. Results are expressed as mean 6 SEM of four experiments.
By paired Student’s t test: *, P , 0.05; **, P , 0.01 (vs. saline
incubations). Basal values were obtained in hepatocytes incubated in
the absence of hormones. EC50 values for insulin are indicated in
boxes.
FIG. 3. Dose-response curve of the in-
sulin effects on pyruvate kinase (panel
A) and PFK-2 (panel B) activities in epi-
nephrine-incubated hepatocytes from
lean (E,F) or obese (M,f) Zucker rats.
Additions to the cell suspensions were
as in Fig. 2. Enzyme activities were
measured in aliquots of the cell suspen-
sions taken after 10 min of incubation.
Results are expressed as mean 6 SEM of
four experiments. By paired Student’s t
test: *, P , 0.05; **, P , 0.01; ***, P ,
0.001 (vs. saline incubations). Basal val-
ues were obtained in hepatocytes incu-
bated in the absence of hormones. EC50
values for insulin are indicated in boxes.
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elevation of F-2,6-P2 levels, as compared with those observed
in lean rat hepatocytes (14.5 6 0.8 and 6.0 6 0.6 nmol/g of
cells, respectively; n 5 4; P , 0.001). Epinephrine provoked
a significant reduction in the F-2,6-P2 content in hepatocytes
isolated from either obese or lean animals (by about 60% and
40%, respectively) (Fig. 4). The additional presence of insulin
in the incubation medium caused a clear increase in the levels
of this metabolite in liver cells from both animal groups;
furthermore, in lean rat hepatocytes, F-2,6-P2 eventually
reached values significantly higher than those measured in
the absence of hormones (P , 0.01). Again, the sensitivity to
insulin seemed to be lower in obese rat hepatocytes than in
cells isolated from lean rats, the EC50 values for insulin cor-
responding to 0.71 and 0.35 nm, respectively (Fig. 4).
To elucidate whether the differences found between obese
and lean rat hepatocytes in the ability of insulin to antagonize
the actions of epinephrine on gluconeogenesis (as well as on
the other metabolic parameters studied) could be caused by
changes in the modulation of the cellular concentrations of
cAMP, the levels of this second messenger were measured.
As shown in Table 1, the basal content of cAMP was similar
in obese and lean rat hepatocytes; the addition of 1 mm
epinephrine to the incubation medium raised the levels of the
cyclic nucleotide about 2-fold in both types of cells. In lean
rat hepatocytes, the additional presence of insulin (10 nm)
reduced the increase in cAMP content caused by epinephrine
by about 80%. In contrast, in hepatocytes isolated from obese
rats, the inhibitory effect of insulin on epinephrine-stimu-
lated cAMP levels was not statistically significant.
Discussion
The mechanisms underlying short-term modulation of he-
patic gluconeogenesis by adrenergic agonists and insulin are
well documented (reviewed in Refs. 21 and 22). In rat hepa-
tocytes incubated under physiological conditions, epineph-
rine has been shown to stimulate gluconeogenesis (17, 27)
through a b-adrenergic receptor-dependent stimulation of
adenylate cyclase and the consequent increase in cAMP lev-
els (27). The increase in the concentration of this second
messenger causes the activation of protein kinase A, which
in turn, phosphorylates and inactivates pyruvate kinase (17).
Protein kinse A also phosphorylates the key enzyme 6-phos-
phofructo 2-kinase/fructose 2,6-bisphosphatase (PFK-2/
FBPase-2), causing the inactivation of PFK-2 (18, 28) and the
activation of FBPase-2 (18, 28). The diminution in the PFK-
2/FBPase-2 activity ratio provokes a decrease in the hepa-
tocyte F-2,6-P2 content. As a consequence of these changes,
epinephrine increases the gluconeogenic flux (22). On the
other hand, insulin is able to antagonize all these epineph-
rine-mediated metabolic changes in a coordinated fashion
(17, 27, 28) through the inhibition of the cellular cAMP in-
crease caused by the catecholamine (22, 27).
According to these concepts, in hepatocytes isolated from
lean (Fa/-) and obese (fa/fa) rats, epinephrine caused a marked
stimulation of lactate gluconeogenesis, a simultaneous inac-
tivation of both pyruvate kinase and PFK-2 activities, and a
marked decrease in F-2,6-P2 levels. In hepatocytes isolated
from lean rats, insulin completely antagonized the stimula-
tion of lactate gluconeogenesis elicited by epinephrine (1
mm), as well as the effects of this adrenergic agent on F-2,6-P2
levels and on pyruvate kinase and PFK-2 activities. In con-
trast, in obese rat hepatocytes, insulin only partially blocked
epinephrine effects on gluconeogenesis and pyruvate kinase
and PFK-2 activities and caused a lower increase in F-2,6-P2
levels than that observed in hepatocytes from lean animals.
These results support the concept of a decreased response of
epinephrine-stimulated gluconeogenesis to insulin counter-
action in obese (fa/fa) rat hepatocytes. Furthermore, in these
cells, the corresponding EC50 values for the action of insulin
on the assayed metabolic parameters were 2- to 4-fold higher
than those estimated for liver cells isolated from lean rats,
FIG. 4. Dose-response curve of the insulin effect on F-2,6-P2 levels in
epinephrine-incubated hepatocytes from lean (E,F) or obese (M,f)
Zucker rats. Additions to the cell suspensions were as in Figure 2.
F-2,6-P2 concentrations were assayed in aliquots of the cell suspen-
sions taken after 10 min of incubation. Results are expressed as
mean 6 SEM of four experiments. By paired Student’s t test: *, P ,
0.05; **, P , 0.01 (vs. saline incubations). Basal values were obtained
in hepatocytes incubated in the absence of hormones. EC50 values for
insulin are indicated in boxes.
TABLE 1. Effects of epinephrine and insulin on the cellular
levels of cAMP in hepatocytes isolated from obese (fa/fa) and lean
(Fa/2) rats
Basal Epinephrine(1 mM)
Epinephrine 1 insulin
(1 mM/10 nM)
Lean rats 0.25 6 0.02 0.55 6 0.07a 0.31 6 0.02b,c
Obese rats 0.25 6 0.03 0.49 6 0.02a 0.43 6 0.03d,c
Hepatocytes were suspended in Krebs-Henseleit medium in the
presence of 10 mM glucose and preincubated for 27 min at 37 C. Then,
saline or insulin were added to the incubation medium. Three minutes
later, a mixture of lactate-pyruvate together with saline or epineph-
rine was added to the incubation medium. After 10 min of incubation,
aliquots of the cell suspensions were taken for cAMP assay. Values are
the mean 6 SEM of three experiments assayed in duplicate and are
expressed as nmol per g of cells. Significance was determined by
paired Student’s t test.
a P , 0.05, epinephrine vs. saline incubations.
b P , 0.05, epinephrine plus insulin vs. epinephrine incubations.
c P , 0.05, epinephrine plus insulin vs. saline incubations.
d P 5 NS, epinephrine plus insulin vs. epinephrine incubations.
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indicating the presence of a reduced sensitivity to insulin in
obese rat hepatocytes.
Insulin resistance in the obese (fa/fa) rats affects liver, mus-
cle, and adipose tissue (3–6). At the hepatic level, these
animals have been shown to display a reduced sensitivity to
the inhibition by insulin of hepatic glucose production (11,
12). In hepatocytes isolated from obese (fa/fa) rats, an im-
paired response to insulin was evidenced in both apo-B li-
poprotein (29, 30) and triacylglycerol secretion (30). Al-
though the primary cause of hepatic insulin resistance in
obese (fa/fa) rats is not fully understood, current evidence
indicates that both receptor and postreceptor events are af-
fected, because decreases in hepatic insulin binding (31) and
insulin receptor tyrosine kinase activity (32) have been re-
ported in these animals. We also found an impairment of a
glycosyl-phosphatidylinositol-dependent insulin signaling
system in hepatocytes isolated from obese (fa/fa) rats (33). On
the other hand, it has been reported that these cells present
a defective function of the inhibitory guanine-nucleotide-
binding protein Gi-2 (34), probably caused by an abnormal
hyperphosphorylation of aGi-2 subunit (35). Recently, it has
been demonstrated that aGi-2 deficiency in mice provokes an
impairment in the actions of insulin in liver, skeletal muscle,
and adipose tissue (36).
With regard to the modulation by insulin of epinephrine-
mediated effects in the liver, we have found no previous data
concerning this hormonal regulation in obese (fa/fa) rats. In
good agreement with our findings, Marette et al. (37) found
similar defects in both sensitivity and responsiveness to in-
sulin in brown adipocytes isolated from obese (fa/fa) rats,
when the inhibitory actions of insulin on norepinephrine-
stimulated oxygen consumption and lipolysis were studied.
As mentioned earlier, the mechanism by which insulin
antagonizes the stimulation of gluconeogenesis by epineph-
rine in isolated rat hepatocytes seems to involve an inhibition
of the cellular cAMP increase caused by the catecholamine
(22, 27). Accordingly, in hepatocytes isolated from lean (Fa/-)
rats, insulin caused an 80% reduction of the 2-fold increase
in cAMP levels elicited by epinephrine. In contrast, insulin
(at this concentration) was unable to reduce significantly the
cellular content of this second messenger in obese rat hepa-
tocytes incubated with epinephrine. This suggests that in
hepatocytes from obese rats, the observed resistance to the
antagonistic effect of insulin on the stimulation of glucone-
ogenesis by epinephrine could be related to a defect in the
modulation by insulin of the epinephrine-mediated increase
in cAMP levels. As mentioned above, hepatocytes isolated
from these animals show a defect in Gi protein function (34,
35), and this abnormality could be responsible, at least in
part, for the impairment of insulin-mediated reduction of
cAMP levels observed in this animal model of insulin
resistance.
It must be mentioned that there is some evidence sug-
gesting that either phenylephrine or epinephrine, apparently
acting through their binding to a1-adrenergic receptors, may
stimulate hepatic gluconeogenesis by a cAMP-independent
mechanism (27, 38–40). Insulin is able to antagonize this
stimulation, in the absence of changes in either the cellular
content of the nucleotide or the activity of protein kinase A
(27, 40). In this regard, it has been suggested that under basal
conditions, insulin could activate both hepatic PFK-2 and
pyruvate kinase by the stimulation of protein phosphatases
(41, 42); it also has been reported that insulin causes a tran-
sient stimulation of a Mg21-dependent pyruvate kinase
phosphatase activity in isolated rat hepatocytes (43). The
operation of this cAMP-independent mechanism of insulin
action could explain the fact that this hormone partially
antagonized epinephrine effects on gluconeogenesis and
F-2,6-P2 levels, as well as on pyruvate kinase and PFK-2
activities in hepatocytes isolated from obese rats, without
significant changes in the cellular content of cAMP (see Table
1). A defective modulation by insulin of this cAMP-inde-
pendent pathway (like the impaired activation of one or
more protein phosphatases) also could contribute to the re-
sistance of epinephrine-stimulated gluconeogenesis to insu-
lin modulation observed in obese rat hepatocytes.
In summary, in obese (fa/fa) Zucker rat hepatocytes, epi-
nephrine-stimulated gluconeogenesis is resistant to short-
term modulation by insulin. That impairment in insulin ac-
tion also affects insulin modulation of epinephrine-mediated
effects on pyruvate kinase and PFK-2 activities and on
F-2,6-P2 levels. Our findings further support the idea that
hepatocytes isolated from obese (fa/fa) rats have an intrinsi-
cally defective response to short-term insulin action (13).
Under epinephrine stimulation conditions, the observed re-
sistance to insulin action seems to arise, at least in part, from
an impairment of the insulin-mediated reduction of hepa-
tocyte cAMP levels in the obese animals.
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